INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2016

May 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2016-05-08

Reporting Person: BENITO SIMON X (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-08	Common Stock	M	5000	—	Acquired	17798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-08	Restricted Stock Unit	$	M	5000	Disposed		Common Stock (5000.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2016.